This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Akouos Crecimiento futuro
Future controles de criterios 0/6
Información clave
32.1%
Tasa de crecimiento de los beneficios
34.9%
Tasa de crecimiento del BPA
Crecimiento de los beneficios de Biotechs | 24.8% |
Tasa de crecimiento de los ingresos | 93.0% |
Rentabilidad financiera futura | n/a |
Cobertura de analistas | Low |
Última actualización | n/a |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Is Akouos (NASDAQ:AKUS) In A Good Position To Deliver On Growth Plans?
Sep 19Akouos stock rises 11% on FDA nod to start gene therapy trial for hearing loss
Sep 13We Think Akouos (NASDAQ:AKUS) Needs To Drive Business Growth Carefully
Jun 04We Think Akouos (NASDAQ:AKUS) Can Afford To Drive Business Growth
Feb 19Companies Like Akouos (NASDAQ:AKUS) Are In A Position To Invest In Growth
Oct 28Here's Why We're Not Too Worried About Akouos' (NASDAQ:AKUS) Cash Burn Situation
Jun 26Akouos names Kathy Reape as chief development officer
May 07We Think Akouos (NASDAQ:AKUS) Can Afford To Drive Business Growth
Mar 04Did Akouos, Inc. (NASDAQ:AKUS) Insiders Buy Up More Shares?
Jan 10Akouos (NASDAQ:AKUS) Is In A Good Position To Deliver On Growth Plans
Nov 18Previsiones de crecimiento de beneficios e ingresos
Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
---|---|---|---|---|---|
12/31/2024 | 10 | -137 | N/A | -87 | 3 |
12/31/2023 | N/A | -117 | N/A | -73 | 4 |
12/31/2022 | N/A | -98 | N/A | -77 | 4 |
9/30/2022 | N/A | -93 | -87 | -74 | N/A |
6/30/2022 | N/A | -96 | -85 | -73 | N/A |
3/31/2022 | N/A | -98 | -76 | -68 | N/A |
12/31/2021 | N/A | -87 | -73 | -64 | N/A |
9/30/2021 | N/A | -74 | -68 | -58 | N/A |
6/30/2021 | N/A | -64 | -58 | -49 | N/A |
3/31/2021 | N/A | -54 | -56 | -48 | N/A |
12/31/2020 | N/A | -49 | -45 | -41 | N/A |
9/30/2020 | N/A | -46 | -44 | -38 | N/A |
6/30/2020 | N/A | -41 | -37 | -33 | N/A |
3/31/2020 | N/A | -30 | -29 | -25 | N/A |
12/31/2019 | N/A | -26 | -23 | -20 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: AKUS is forecast to remain unprofitable over the next 3 years.
Beneficios vs. Mercado: AKUS is forecast to remain unprofitable over the next 3 years.
Beneficios de alto crecimiento: AKUS is forecast to remain unprofitable over the next 3 years.
Ingresos vs. Mercado: AKUS is forecast to have no revenue next year.
Ingresos de alto crecimiento: AKUS is forecast to have no revenue next year.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Insufficient data to determine if AKUS's Return on Equity is forecast to be high in 3 years time